Related Experiment Videos

Suppressor cells for cell-mediated immunity in infectious diseases

¹Department of Experimental Immunobiology, Wellcome Research Laboratories, Beckenham, Kent, GB.

Research in Immunology

|March 1, 1989

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

IL-33 Exacerbates Periodontal Disease through Induction of RANKL.

Journal of dental research·2015

Regulation of delayed-type hypersensitivity to pathogens and alloantigens.

Immunology today·2014

IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice.

Mucosal immunology·2014

An interleukin-33/ST2 signaling deficiency reduces overt pain-like behaviors in mice.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2013

IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2.

British journal of pharmacology·2013

Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice.

Allergy·2012

See all related articles